Cranebio
Company

Last deal

Amount

Series A

Stage

04.10.2023

Date

1

all rounds

General

About Company
Cranebio develops wearable health care, genetic test, and environmental test kits.

Industry

Sector :

Subsector :

founded date

15.04.2021

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Developer of medical testing systems intended to provide simple, sensitive and affordable medical testing kits. The company develops viral or bacterial gene testing kits and wearable testing kits focused on hormones and diseases peculiar to women, enabling female users to access an epoch-making product that does not require the troublesome collection of blood and urine.